- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by Telsar Pharma Inc.
Total 2423 results
-
Astellas Pharma Global Development, Inc.CompletedHot FlashesUnited States, Canada, Czechia, United Kingdom, Latvia, Poland, Spain
-
Astellas Pharma Global Development, Inc.CompletedHealthy Volunteers | Hepatic ImpairmentUnited States
-
Astellas Pharma Global Development, Inc.CompletedCytomegalovirus (CMV)-Positive Recipients | Allogeneic, Hematopoietic Cell Transplant (HCT)Japan, Korea, Republic of, United States, Canada, Australia, Belgium, France, Germany, Spain, Sweden, Taiwan
-
Astellas Pharma Global Development, Inc.CompletedAcute Myeloid Leukemia (AML) | Acute Myeloid Leukemia With FMS-like Tyrosine Kinase (FLT3) MutationUnited States
-
Astellas Pharma Global Development, Inc.Completed
-
Astellas Pharma Global Development, Inc.Completed
-
Astellas Pharma Global Development, Inc.CompletedMetastatic Renal Cell CarcinomaUnited States, Canada
-
Astellas Pharma Global Development, Inc.Approved for marketingAcute Myeloid Leukemia (AML) | FMS-like Tyrosine Kinase-3 (FLT3) MutationsUnited States, Canada, Japan
-
Astellas Pharma Global Development, Inc.CompletedFibromyalgiaUnited States
-
Astellas Pharma Global Development, Inc.Completed
-
Astellas Pharma Global Development, Inc.CompletedRelapsed Lymphoid Malignancy | Refractory Lymphoid MalignancyUnited States, Canada
-
Astellas Pharma Global Development, Inc.CompletedHealthy VolunteersUnited States
-
Astellas Pharma Global Development, Inc.CompletedOveractive Bladder (OAB)United States, Canada
-
Astellas Pharma Global Development, Inc.CompletedNon-Small-Cell Lung Cancer (NSCLC) | Epidermal Growth Factor Receptor MutationsUnited States
-
Astellas Pharma Global Development, Inc.CompletedCLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction | CLDN18.2-positive Adenocarcinoma of Esophagus | CLDN18.2-positive Gastric AdenocarcinomaGermany, Latvia
-
Astellas Pharma Global Development, Inc.WithdrawnHealthy Volunteers
-
Astellas Pharma Global Development, Inc.CompletedRheumatoid Arthritis (RA)United States, Poland
-
Astellas Pharma Global Development, Inc.CompletedLymphoma | Advanced Cancer | Refractory Solid TumorsUnited States
-
Astellas Pharma Global Development, Inc.Completed
-
Astellas Pharma Global Development, Inc.CompletedRheumatoid ArthritisMoldova, Republic of
-
Astellas Pharma Global Development, Inc.CompletedAdvanced Solid Tumors | Pharmacokinetics of 14C-OSI-906United States
-
Astellas Pharma IncAstellas Pharma Global Development, Inc.CompletedSolid TumorsUnited States, Japan, Korea, Republic of, Taiwan
-
Astellas Pharma Global Development, Inc.No longer availableAcute Myeloid Leukemia (AML) | FMS-like Tyrosine Kinase-3 (FLT3) MutationsAustralia, Italy, United Kingdom
-
Astellas Pharma Global Development, Inc.TerminatedNon-small Cell Lung Cancer (NSCLC) | Epidermal Growth Factor Receptor (EGFR) MutationsUnited States
-
Astellas Pharma Global Development, Inc.CompletedHealthy Volunteers | Pharmacokinetics of ASP1941United States
-
Astellas Pharma Global Development, Inc.Not yet recruitingClaudin 18.2 (CLDN18.2) Positive Metastatic Pancreatic Adenocarcinoma
-
Astellas Pharma Global Development, Inc.RecruitingNeurogenic Detrusor OveractivityPhilippines, Turkey, Belgium, Denmark
-
Astellas Pharma Global Development, Inc.RecruitingAcute Myeloid Leukemia (AML) | FLT3-mutated Acute Myeloid LeukemiaUnited States
-
Astellas Pharma Global Development, Inc.RecruitingAcute Myeloid Leukemia (AML) | Acute Myeloid Leukemia With FMS-like Tyrosine Kinase 3 (FLT3) Mutation / Internal Tandem Duplication (ITD)United States, Canada, Germany, Italy, Spain, United Kingdom, France
-
Astellas Pharma Global Development, Inc.Active, not recruitingAge-Related Macular Degeneration | Geographic AtrophyUnited States, Italy, Latvia, France, Israel, Germany, Spain, Hungary, Brazil, Canada, Argentina, Colombia, Croatia, Australia, Austria, Belgium, Czechia
-
Astellas Pharma Global Development, Inc.Active, not recruitingLocally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer | Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer | Metastatic Gastric Adenocarcinoma or Cancer | Metastatic Gastroesophageal Junction (GEJ) AdenocarcinomaUnited States, Australia, Belgium, Brazil, Canada, Chile, China, Colombia, France, Germany, Israel, Italy, Japan, Korea, Republic of, Mexico, Peru, Poland, Spain, Taiwan, United Kingdom
-
Astellas Pharma Global Development, Inc.Active, not recruitingAdvanced Cancer | Advanced MalignanciesUnited States
-
Astellas Pharma Global Development, Inc.Active, not recruitingAcute Myeloid Leukemia (AML) | Acute Myeloid Leukemia With FMS-like Tyrosine Kinase (FLT3) MutationUnited States, Japan, Taiwan, Spain, Australia, Belgium, Canada, France, Germany, Italy, Korea, Republic of, Poland, United Kingdom
-
Astellas Pharma Global Development, Inc.CompletedInvasive Aspergillosis | Invasive MucormycosisUnited States, Belgium, Spain
-
Astellas Pharma Global Development, Inc.TerminatedReduced Maximum Oxygen Uptake Due to Poor Systemic Oxygen ExtractionUnited States
-
Astellas Pharma Global Development, Inc.CompletedMyelodysplastic Syndrome | Acute Myeloid Leukemia (AML)United States, Japan
-
Astellas Pharma Global Development, Inc.CompletedHot FlashesUnited States, Canada, Czechia, Hungary, Poland, Spain, United Kingdom
-
Astellas Pharma Global Development, Inc.CompletedRenal Impairment | Healthy VolunteersUnited States
-
Astellas Pharma Global Development, Inc.Completed
-
Astellas Pharma Global Development, Inc.CompletedAcute Myeloid LeukemiaUnited States
-
Astellas Pharma Global Development, Inc.Completed
-
Astellas Pharma Global Development, Inc.CompletedHealthy SubjectsUnited States
-
Astellas Pharma Global Development, Inc.Completed
-
Astellas Pharma Global Development, Inc.CompletedTumors | Incurable Platinum Refractory Germ Cell TumorsUnited States
-
Astellas Pharma Global Development, Inc.TerminatedAcute Myeloid LeukemiaCanada, United States
-
Astellas Pharma Global Development, Inc.Completed
-
Astellas Pharma Global Development, Inc.CompletedOveractive Bladder (OAB)United States, Canada
-
Astellas Pharma Global Development, Inc.CompletedHealthy | Hepatic ImpairmentUnited States
-
Astellas Pharma Global Development, Inc.CompletedInvasive Fungal InfectionUnited States
-
Astellas Pharma Global Development, Inc.CompletedOveractive Bladder | Benign Prostatic HyperplasiaUnited States, Canada, Czechia, France, Germany, Italy, Poland, Spain, United Kingdom